Discover the Future Standard of Spectral Flow Cytometry

Spectral flow cytometry is entering a new era, now defined by the ability to perform high parameter analysis while obtaining reproducible results with ease. We will introduce the BD FACSDiscover™ A7 from Waters Biosciences, formerly BD Biosciences – a new spectral analyzer purpose-built to deliver consistent, robust performance with streamlined, easy-to-use workflows. Through continued innovation on the BD FACSDiscover™ Platform, this analyzer sets a new standard for reproducible spectral data, allowing laboratories worldwide to obtain high-quality flow cytometry results day-after-day with ease. We will describe the fundamental challenges and opportunities of spectral standardization and illustrate how Waters Biosciences, formerly BD Biosciences is advancing technology to unlock this next phase of flow cytometry. Beyond standardization, we will share how researchers from around the globe are currently exploring new scientific applications of cytometry with the BD FACSDiscover™ Platform. Real-time imaging combined with spectral analysis on the BD FACSDiscover™ S8 and BD FACSDiscover™ A8 Instruments – equipped with BD CellView™ Image and BD SpectralFX™ Technologies – is broadening what types of biology can be measured using flow cytometry, while also reducing experimental complexity. We will present several application examples in areas such as immuno-oncology, ultra-high parameter immunophenotyping, as well as highlight multiple exciting advancements in cytometry using the BD FACSDiscover™ Platform.